SEC Form 4 · accession 0001127602-16-049566
Encompass Health Corp · EHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Chidsey
Director
Period of report
Apr 19, 2016
Accepted (ET)
Apr 20, 2016 · 2:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000785161
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Healthsouth Common StockF1,F2 | Apr 19, 2016 | A | 1,015 | $37.07 | A | 90,340 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This number represents the purchase of (a) 775 shares of common stock of HealthSouth Corporation (the "Company") pursuant to an election by the reporting person to participate in the Directors Deferred Stock Investment Plan of the Company (the "Plan") and (b) 240 shares associated with cash dividends on shares of the Company's common stock held under the Plan. The Plan is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2015 to defer fixed percentages of their directors fees for 2016. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. On April 15, 2016, the Company paid a dividend on common stock of $0.23 per share. The transactions reported on this Form 4 are the acquisitions under the Plan of shares of common stock of the Company in the market for the account of the reporting person for an aggregate purchase price equal to the sum of (i) the amount of fees deferred by the reporting person for the current quarter of 2016 and (ii) the cumulative dividends paid on the common stock held in the associated deferred account.
- F2This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $37.050 to $37.072, inclusive. The reporting person undertakes to provide to HealthSouth Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.